Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 1802518-92-8
2. Minzasolmin [inn]
3. 3n0435tg2d
4. Unii-3n0435tg2d
5. (r)-n-(1-(1h-indol-3-yl)hexan-2-yl)-2-(4-methylpiperazin-1-yl)thiazole-5-carboxamide
6. 5-thiazolecarboxamide, N-((1r)-1-(1h-indol-3-ylmethyl)pentyl)-2-(4-methyl-1-piperazinyl)-
7. 5-thiazolecarboxamide, N-[(1r)-1-(1h-indol-3-ylmethyl)pentyl]-2-(4-methyl-1-piperazinyl)-
8. N-((1r)-1-(1h-indol-3-ylmethyl)pentyl)-2-(4-methylpiperazin-1-yl)thiazole-5-carboxamide
9. N-[(2r)-1-(1h-indol-3-yl)hexan-2-yl]-2-(4-methylpiperazin-1-yl)-1,3-thiazole-5-carboxamide
10. Minzasolmina
11. Minzasolmine
12. (r)-n-[1-(1h-indol-3-yl)hexan-2-yl]-2-(4-methylpiperazin-1-yl)thiazole-5-carboxamide
13. N-[(1r)-1-(1h-indol-3-ylmethyl)pentyl]-2-(4-methylpiperazin-1-yl)thiazole-5-carboxamide
14. Minzasolmin (usan/inn)
15. Minzasolmin [usan]
16. Dlx313
17. Chembl5095072
18. Schembl16973853
19. Dlx-313
20. Bdbm510823
21. Glxc-26948
22. Ex-a6318
23. Ucb-0599
24. Da-65474
25. Hy-145580
26. Us11078196, Ex. 28
27. Cs-0376408
28. D12796
29. (r)-n-(1-(1h-indol-3-yl)hexan- 2-yl)-2-(4-methylpiperazin-1- Yl)thiazole-5-carboxamide
30. N-[(1r)-1-(1h-indol-3-ylmethyl)pentyl]-2-(4-methyl-1-piperazinyl)-5-thiazolecarboxamide
| Molecular Weight | 425.6 g/mol |
|---|---|
| Molecular Formula | C23H31N5OS |
| XLogP3 | 4.8 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 8 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 92.5 |
| Heavy Atom Count | 30 |
| Formal Charge | 0 |
| Complexity | 556 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
76
PharmaCompass offers a list of Minzasolmin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Minzasolmin manufacturer or Minzasolmin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Minzasolmin manufacturer or Minzasolmin supplier.
PharmaCompass also assists you with knowing the Minzasolmin API Price utilized in the formulation of products. Minzasolmin API Price is not always fixed or binding as the Minzasolmin Price is obtained through a variety of data sources. The Minzasolmin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Minzasolmin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Minzasolmin, including repackagers and relabelers. The FDA regulates Minzasolmin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Minzasolmin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Minzasolmin supplier is an individual or a company that provides Minzasolmin active pharmaceutical ingredient (API) or Minzasolmin finished formulations upon request. The Minzasolmin suppliers may include Minzasolmin API manufacturers, exporters, distributors and traders.
Minzasolmin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Minzasolmin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Minzasolmin GMP manufacturer or Minzasolmin GMP API supplier for your needs.
A Minzasolmin CoA (Certificate of Analysis) is a formal document that attests to Minzasolmin's compliance with Minzasolmin specifications and serves as a tool for batch-level quality control.
Minzasolmin CoA mostly includes findings from lab analyses of a specific batch. For each Minzasolmin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Minzasolmin may be tested according to a variety of international standards, such as European Pharmacopoeia (Minzasolmin EP), Minzasolmin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Minzasolmin USP).
